1. Academic Validation
  2. Mammalian forebrain ketimine reductase identified as μ-crystallin; potential regulation by thyroid hormones

Mammalian forebrain ketimine reductase identified as μ-crystallin; potential regulation by thyroid hormones

  • J Neurochem. 2011 Aug;118(3):379-87. doi: 10.1111/j.1471-4159.2011.07220.x.
André Hallen 1 Arthur J L Cooper Joanne F Jamie Paul A Haynes Robert D Willows
Affiliations

Affiliation

  • 1 Department of Chemistry and Biomolecular Sciences, Macquarie University, North Ryde, New South Wales, Australia.
Abstract

Ketimine reductase (E.C. 1.5.1.25) was purified to apparent homogeneity from lamb forebrain by means of a rapid multi-step chromatography protocol. The purified Enzyme was identified by MS/MS (mass spectrometry) as μ-crystallin. The identity was confirmed by heterologously expressing human μ-crystallin in Escherichia coli and subsequent chromatographic purification of the protein. The purified human μ-crystallin was confirmed to have ketimine reductase activity with a maximum specific activity similar to that of native ovine ketimine reductase, and was found to catalyse a sequential reaction. The Enzyme substrates are putative neuromodulator/transmitters. The thyroid hormone 3,5,3'-l-triiodothyronine (T3) was found to be a strong reversible competitive inhibitor, and may have a novel role in regulating their concentrations. μ-Crystallin is also involved in intracellular T3 storage and transport. This research is the first to demonstrate an Enzyme function for μ-crystallin. This newly demonstrated enzymatic activity identifies a new role for thyroid Hormones in regulating mammalian amino acid metabolism, and a possible reciprocal role of Enzyme activity regulating bioavailability of intracellular T3.

Figures